Health Care & Life Sciences » Biotechnology | VBI Vaccines Inc.

VBI Vaccines Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
955.00
548.00
865.00
3,355
Cost of Goods Sold (COGS) incl. D&A
4,986.80
32.00
3,753.00
3,671.00
5,193.00
4,509
Gross Income
4,986.80
32.00
2,798.00
3,123.00
4,328.00
1,154
SG&A Expense
2,511.30
5,519.60
20,961.00
21,727.00
32,952.00
58,976
EBIT
7,498.10
5,551.60
-
24,850.00
37,280.00
60,130
Non Operating Income/Expense
265.00
151.50
1,458.00
189.00
736.00
560
Interest Expense
-
-
1,105.00
324.00
2,882.00
3,254
Pretax Income
6,760.30
4,821.20
26,322.00
24,985.00
39,426.00
63,600
Income Tax
-
-
129.00
1,780.00
431.00
-
Consolidated Net Income
6,760.30
4,821.20
26,193.00
23,205.00
38,995.00
63,600
Net Income
6,760.30
4,821.20
26,193.00
23,205.00
38,995.00
63,600
Net Income After Extraordinaries
6,760.30
4,821.20
26,193.00
23,205.00
38,995.00
63,600
Net Income Available to Common
6,760.30
4,821.20
26,193.00
23,205.00
38,995.00
63,600
EPS (Basic)
1.20
0.96
1.27
0.77
0.88
0.97
Basic Shares Outstanding
4,995.30
4,996.40
12,630.20
30,043.50
44,158.70
65,647.80
EPS (Diluted)
1.35
0.96
2.07
0.77
0.88
0.97
Diluted Shares Outstanding
4,995.30
4,996.40
12,630.20
30,043.50
44,158.70
65,647.80
EBITDA
7,462.70
5,519.60
23,267.00
24,244.00
36,550.00
59,588
Non-Operating Interest Income
472.90
578.90
-
-
-
622

About VBI Vaccines

View Profile
Address
222 3rd Street
Cambridge Massachusetts 02142
United States
Employees -
Website http://www.vbivaccines.com
Updated 07/08/2019
VBI Vaccines, Inc. is a biopharmaceutical company, which develops vaccines for infectious disease and immuno-oncology. Its pipeline includes Sci-B-Vac, CMV Vaccine, GBM Immunotherapy, MB Immunotherapy, and Zika Vaccine. The company was founded on July 9, 2015 is headquartered in Cambridge, MA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.